← Back to home

HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 PATHOLOGIC STAGE

Clinical trials for HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 PATHOLOGIC STAGE explained in plain language.

Never miss a new study

Get alerted when new HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 PATHOLOGIC STAGE trials appear

Sign up with your email to follow new studies for HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 PATHOLOGIC STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Blood test may tailor throat cancer treatment, sparing patients from harsh side effects

Disease control Recruiting now

This trial tests whether a blood test that detects HPV DNA can help doctors personalize treatment for people with HPV-related throat cancer. Participants receive radiation therapy, with or without chemotherapy, but the intensity is adjusted based on their blood test results and c…

Matched conditions: HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 PATHOLOGIC STAGE

Phase: PHASE2 • Sponsor: Jonathan Schoenfeld, MD, MPH • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC

HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 PATHOLOGIC STAGE

Get alerted when new HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 PATHOLOGIC STAGE trials appear

Blood test may tailor throat cancer treatment, sparing patients from harsh side effects